Is Drug Screening in 3D Ready for Automation?
New Frontiers in 3D | Visionaries Speak
by InSphero
1y ago
Our Panelists Dr. Terry Riss, Senior Product Manager, Cell Health, Promega Corporation Dr. Terry Riss started the Cell Biology program at Promega Corporation in 1990. He managed the development of cell viability, cytotoxicity, apoptosis, and protease assay systems and lead efforts to identify and promote multiplexing of cell-based assays to determine the mechanism of cell death. He now serves as Senior Product Manager, Cell Health, involved in outreach educational training activities, including validating assay systems applied to 3D cell culture models. Terry is also an editor of the In Vitro ..read more
Visit website
T1D: Emerging Perspectives on Disease Pathogenesis, Prevention and Treatment
New Frontiers in 3D | Visionaries Speak
by InSphero
1y ago
Our Panelists Prof. Matthias Hebrok, Professor at the Diabetes Center at the University of California San Francisco Matthias Hebrok is Hurlbut-Johnson Distinguished Professor in Diabetes Research at the Diabetes Center at the University of California San Francisco. He received his Diploma degree in Cell Biology from the Albert-Ludwigs University, performed his PhD thesis at the Max-Planck-Institute, and conducted his postdoctoral research at HHMI at Harvard University. His laboratory has made seminal contributions to our understanding of how embryonic signals control the fetal development of t ..read more
Visit website
Does Physiological Complexity Kill Scalability?
New Frontiers in 3D | Visionaries Speak
by InSphero
1y ago
Our Panelists Academic Perspective Prof. Jaap den Toonder, Professor and Chair of the Microsystems section, Eindhoven University of Technology Jaap is a full professor and Chair of the Microsystems section at Eindhoven University of Technology, and former Principal Scientist and Chief Technologist at Philips Research. He received his PhD in Mechanical Engineering from Delft University of Technology. His research focuses on the investigation and development of novel microsystems design approaches and out-of-cleanroom fabrication technologies. His application focus is on microfluidic chips, biom ..read more
Visit website
Animal-Free Drug Safety Testing: Challenges and Opportunities
New Frontiers in 3D | Visionaries Speak
by InSphero
1y ago
This episode aired originally live at https://newfrontiersin3d.com/ In this podcast we address key questions, such as: Do animals predict human drug safety correctly? What are the general limitations? How can we increase predictivity of drug safety for patients? What are the challenges for evaluating new therapeutic modalities? What are the most promising new animal-free technologies and testing strategies for risk assessment? What will drug safety risk assessment look like in 2030? Our Speakers Pharmaceutical Industry Perspective Dr. Stefan Platz, Senior Vice President and Head of Clinical ..read more
Visit website

Follow New Frontiers in 3D | Visionaries Speak on Feedspot

Continue with Google
OR